MAI Wealth Advisors »

Sonoma Pharmaceuticals shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Sonoma Pharmaceuticals (SNOA) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Sonoma Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Sonoma Pharmaceuticals held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sonoma Pharmaceuticals by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $482 124 3.89

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Alphabet Call Call Option (Principal) (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Sonoma Pharmaceuticals

Vanguard Group
Geode Capital Management
DRW Holdings
Tower Research Capital
Rockefeller Capital Management
Global Retirement Partners
MAI Wealth Advisors
Jpmorgan Chase & Co
BlackRock
UBS Group
Us Bancorp
Morgan Stanley
Hanson McClain Advisors
Quaker Wealth Management
FMR

View all funds holding Sonoma Pharmaceuticals